CoChat

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

Open access
Dunne, Richard F., Hezel, Aram F. · 2015 · Hematology/Oncology Clinics of North America
Cited by 66

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignancy that carries a poor prognosis with a 5-year survival on the order of 6%1; new and innovative treatments are needed. Several factors underlie its aggressive nature and resistance to treatment: the genetic framework, early metastasis, a dense stroma, propensity for growth in a nutrient-deplete environment, and immunomodulation have all made therapeutic progress a challenge.2 This article focuses on recent advances in understanding the tumor genetics and cell biology of pancreatic cancer. It reviews the established genetic hallmarks, examines more recently described mutations and altered pathways, and highlights key biological principles identified in PDA with a focus on those most likely to lead to future therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hoc.2015.04.003

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

Metadata

Authors
Dunne, R. F., & Hezel, A. F.
Venue
Hematology/Oncology Clinics of North America
Publisher
Elsevier BV
Published
2015-08
Volume
29
Issue
4
Pages
595-608
ISSN
0889-8588 (ISSN-L)
OpenAlex
W2107416007
Cited by
66
References
39
FWCI
2.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.